These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Stone DM; Stahl DC; Hanson GR; Gibb JW Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893 [TBL] [Abstract][Full Text] [Related]
3. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Battaglia G; Yeh SY; De Souza EB Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449 [TBL] [Abstract][Full Text] [Related]
4. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Stone DM; Merchant KM; Hanson GR; Gibb JW Neuropharmacology; 1987 Dec; 26(12):1677-83. PubMed ID: 2893986 [TBL] [Abstract][Full Text] [Related]
5. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
6. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. Ali SF; Newport GD; Scallet AC; Binienda Z; Ferguson SA; Bailey JR; Paule MG; Slikker W Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472 [TBL] [Abstract][Full Text] [Related]
7. Orally administered MDMA causes a long-term depletion of serotonin in rat brain. Finnegan KT; Ricaurte GA; Ritchie LD; Irwin I; Peroutka SJ; Langston JW Brain Res; 1988 Apr; 447(1):141-4. PubMed ID: 2898273 [TBL] [Abstract][Full Text] [Related]
8. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Li AA; Marek GJ; Vosmer G; Seiden LS Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905 [TBL] [Abstract][Full Text] [Related]
9. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631 [TBL] [Abstract][Full Text] [Related]
10. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. Ricaurte GA; Martello AL; Katz JL; Martello MB J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470 [TBL] [Abstract][Full Text] [Related]
11. 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. Ricaurte GA; Finnegan KF; Nichols DE; DeLanney LE; Irwin I; Langston JW Eur J Pharmacol; 1987 Jun; 137(2-3):265-8. PubMed ID: 2886355 [TBL] [Abstract][Full Text] [Related]
12. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Colado MI; Green AR Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800 [TBL] [Abstract][Full Text] [Related]
13. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats. Stone DM; Hanson GR; Gibb JW Neuropharmacology; 1987 Nov; 26(11):1657-61. PubMed ID: 2448703 [TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [TBL] [Abstract][Full Text] [Related]
15. Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine. Hashimoto K; Goromaru T Neuropharmacology; 1990 Jul; 29(7):633-9. PubMed ID: 1696701 [TBL] [Abstract][Full Text] [Related]
17. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration. Johnson MP; Nichols DE Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831 [TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824 [TBL] [Abstract][Full Text] [Related]
19. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
20. (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Kelland MD; Freeman AS; Chiodo LA Eur J Pharmacol; 1989 Oct; 169(1):11-21. PubMed ID: 2574685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]